DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 7.2% of their position (4.40K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $44.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/7/2024ACC: 0001628280-24-046462
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
-4.40K
Net shares
Net seller
$44.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.40K
Price / share
$10.11
Trade value
$44.45K
% of position
7.2%
11/6/2024
61.37K→56.97K
Total
Net shares
−4.40K
Net value
-$44.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/6/2024 | S · Sale | −4.40K | $10.11 | $44.45K | 7.2% | 61.37K | 56.97K |
| Total | −4.40K | -$44.45K | ||||||
Derivative Transactions0
No derivative transactions reported